These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9857920)

  • 1. Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre. Experience in 1082 patients.
    Cortigiani L; Lombardi M; Landi P; Paolini EA; Nannini E
    Eur Heart J; 1998 Nov; 19(11):1673-80. PubMed ID: 9857920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting.
    Cortigiani L; Picano E; Coletta C; Chiarella F; Mathias W; Gandolfo N; De Alcantara M; Mazzoni V; Gensini GF; Landi P; ;
    Am Heart J; 2001 Apr; 141(4):621-9. PubMed ID: 11275930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease.
    Cortigiani L; Dodi C; Paolini EA; Bernardi D; Bruno G; Nannini E
    J Am Coll Cardiol; 1998 Dec; 32(7):1975-81. PubMed ID: 9857881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups.
    Pingitore A; Picano E; Varga A; Gigli G; Cortigiani L; Previtali M; Minardi G; Colosso MQ; Lowenstein J; Mathias W; Landi P
    J Am Coll Cardiol; 1999 Nov; 34(6):1769-77. PubMed ID: 10577568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-early risk stratification after myocardial infarction via pharmacological stress echocardiography: the relative value of resting function, viability and myocardial ischemia.
    Sclavo M; Aruta E; Presbitero P
    G Ital Cardiol; 1997 Oct; 27(10):1000-7. PubMed ID: 9359049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of residual ischaemia assessed by exercise electrocardiography and dobutamine stress echocardiography in low-risk patients following acute myocardial infarction.
    Bigi R; Galati A; Curti G; Coletta C; Barlera S; Partesana N; Bordi L; Ceci V; Occhi G; Fiorentini C
    Eur Heart J; 1997 Dec; 18(12):1873-81. PubMed ID: 9447314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies.
    Cortigiani L; Picano E; Landi P; Previtali M; Pirelli S; Bellotti P; Bigi R; Magaia O; Galati A; Nannini E
    J Am Coll Cardiol; 1998 Jul; 32(1):69-74. PubMed ID: 9669251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin.
    Dodi C; Cortigiani L; Masini M; Olivotto I; Azzarelli A; Nannini E
    Eur Heart J; 2001 Jan; 22(2):145-52. PubMed ID: 11161916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac complications in noncardiac surgery: value of dobutamine stress echocardiography versus dipyridamole thallium imaging.
    Kontos MC; Akosah KO; Brath LK; Funai JT; Mohanty PK
    J Cardiothorac Vasc Anesth; 1996 Apr; 10(3):329-35. PubMed ID: 8725412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study.
    Sicari R; Landi P; Picano E; Pirelli S; Chiarandà G; Previtali M; Seveso G; Gandolfo N; Margaria F; Magaia O; Minardi G; Mathias W; ;
    Eur Heart J; 2002 Jul; 23(13):1030-7. PubMed ID: 12093055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of dipyridamole or dobutamine stress echocardiography for evaluation of patients > or =65 years of age with known or suspected coronary heart disease.
    Cortigiani L; Bigi R; Sicari R; Landi P; Bovenzi F; Picano E
    Am J Cardiol; 2007 Jun; 99(11):1491-5. PubMed ID: 17531567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study.
    Steinberg EH; Madmon L; Patel CP; Sedlis SP; Kronzon I; Cohen JL
    J Am Coll Cardiol; 1997 Apr; 29(5):969-73. PubMed ID: 9120183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease.
    Severino S; Dandrea A; Caso P; Celentano E; De Simone L; Liccardo B; Morra P; Cicala S; Astarita C; Mininni N
    Ital Heart J; 2001 Apr; 2(4):256-64. PubMed ID: 11374494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain.
    Cortigiani L; Paolini EA; Nannini E
    Circulation; 1998 Dec 22-29; 98(25):2855-9. PubMed ID: 9860787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block.
    Cortigiani L; Picano E; Vigna C; Lattanzi F; Coletta C; Mariotti E; Bigi R;
    Am J Med; 2001 Apr; 110(5):361-9. PubMed ID: 11286950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease.
    Poldermans D; Fioretti PM; Boersma E; Cornel JH; Borst F; Vermeulen EG; Arnese M; el-Hendy A; Roelandt JR
    Am J Med; 1994 Aug; 97(2):119-25. PubMed ID: 8059777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients.
    Cortigiani L; Zanetti L; Bigi R; Desideri A; Fiorentini C; Nannini E
    J Hypertens; 2002 Jul; 20(7):1423-9. PubMed ID: 12131540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pharmacologic stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test.
    Pratali L; Otasevic P; Neskovic A; Molinaro S; Picano E
    J Card Fail; 2007 Dec; 13(10):836-42. PubMed ID: 18068617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stress echo prognostic gender gap.
    Cortigiani L; Gigli G; Vallebona A; Mariani PR; Bigi R; Desideri A
    Eur J Echocardiogr; 2001 Jun; 2(2):132-8. PubMed ID: 11882441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole stress echocardiography and exercise testing for risk stratification after uncomplicated myocardial infarction.
    Desideri A; Suzzi GL; Terlizzi R; Canel F; Cernetti C; Celegon L
    G Ital Cardiol; 1998 Jul; 28(7):754-9. PubMed ID: 9773299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.